Estradiol phenylpropionate
http://dbpedia.org/resource/Estradiol_phenylpropionate an entity of type: Thing
Estradiol phenylpropionate (EPP), also known as estradiol 17β-phenylpropionate and sold under the brand name Menformon Prolongatum, is an estrogen which is no longer marketed. It is an estrogen ester, specifically the C17β phenylpropionate ester of estradiol. The pharmacokinetics of EPP in combination with estradiol benzoate have been studied.
rdf:langString
rdf:langString
Estradiol phenylpropionate
xsd:integer
50777091
xsd:integer
1104317362
xsd:integer
27
xsd:integer
26443
xsd:integer
1974118
xsd:integer
61847
xsd:integer
32
rdf:langString
[-3-Hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] 3-phenylpropanoate
xsd:integer
3
xsd:integer
68577
rdf:langString
CC12CCC3CCCC5=C3C=CCO
xsd:integer
1
rdf:langString
LQWSQQKTZLDGME-RYIFMDQWSA-N
rdf:langString
Estradiol phenpropionate; Estradiol benzenepropionate; Estradiol phenylpropanoate; Estradiol benzenepropanoate
rdf:langString
Menformon Prolongatum, Dimenformon Prolongatum, Lynandron Prolongatum
rdf:langString
LS956OGN6U
xsd:integer
250
rdf:langString
Estradiol phenylpropionate (EPP), also known as estradiol 17β-phenylpropionate and sold under the brand name Menformon Prolongatum, is an estrogen which is no longer marketed. It is an estrogen ester, specifically the C17β phenylpropionate ester of estradiol. EPP has been marketed in combination with estradiol benzoate under the brand name Dimenformon Prolongatum in Europe and in combination with estradiol benzoate, testosterone propionate, testosterone phenylpropionate, and testosterone isocaproate under the brand names Mixogen, Estandron Prolongatum, and Lynandron Prolongatum (a balanced mixture of estradiol and testosterone esters) in menopausal hormone therapy. Both of these medication combinations are long-acting injectables indicated in hormone replacement therapy for women in menopause. Dimenformon Prolongatum has also been investigated as a single injection, "morning after" post-coital contraceptive, and is additionally used as a component of hormone replacement therapy for transgender women. The pharmacokinetics of EPP in combination with estradiol benzoate have been studied.
xsd:nonNegativeInteger
6591
rdf:langString
Menformon Prolongatum, Dimenformon Prolongatum, Lynandron Prolongatum
xsd:string
26443-03-8
xsd:string
1974118
xsd:string
LS956OGN6U
xsd:string
68577